Clinical Trial Update: The Role of ImmuKnow® in the Management of Immunosuppressants in the Renal Transplant Patient [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating the use of ImmuKnow to guide immunosuppressant management in kidney transplant recipients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Transplantation

Drugs mentioned

• ImmuKnow

Snippet

Sponsor: CAMC Health System | Conditions: Kidney Transplant Immunosuppression | Phase 4 | Status: TERMINATED